2025/09/12 by Aliya Sajid, Sanaria Fathulla, Dr Samantha Borland
#Protein Kinase Cα (PKCα) #Vascular Calcification #cardiovascular research #chronic kidney disease #clinical applications #immunohistochemistry #micro-CT #molecular signalling pathways #personalised medicine #therapeutic strategies
paper · doi:10.57898/bioscientist.305
Vascular calcification is a significant health concern, particularly for individualswith chronic kidney disease, yet no approved treatments currently exist.Understanding the molecular mechanisms underlying this process is crucial fordeveloping effective therapeutic strategies. This interview explores theresearch journey of Dr. Samantha Borland, tracing her academic background, keydiscoveries, and ongoing investigations into the role of Protein Kinase Cα(PKCα) in vascular calcification. Dr. Borland discusses the potential oftargeted therapies, including drug repurposing and natural compounds, andhighlights the challenges associated with translating research findings intoclinical applications. The discussion also emphasises the importance ofinterdisciplinary collaboration and future directions in combating vascularcalcification.